Details for Patent: 7,265,124

✉ Email this page to a colleague

Summary for Patent: 7,265,124

Title:	Cristalline and amorphous form of a triazolo (4,5-D) pyridimine compound
Abstract:	The invention provides new forms of a chemical compound of formula (I). The invention relates to forms of a chemical compound (I), in particular to crystalline and amorphous forms, more particularly four crystalline forms and an amorphous form. The invention further relates to processes for the preparation of such forms, to pharmaceutical compositions comprising the compound in crystalline and/or amorphous form and to therapeutic use of such forms.
Inventor(s):	Bohlin; Martin (Sodertalje, SE), Cosgrove; Steve (Loughborough, GB), Lassen; Bo (Sodertalje, SE)
Assignee:	AstraZeneca AB (Sodertalje, SE)
Application Number:	11/240,801
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 7,265,124
Patent Claim Types: see list of patent claims	Compound; Process; Composition; Use;

Drugs Protected by US Patent 7,265,124

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

Foreign Priority and PCT Information for Patent: 7,265,124

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
United Kingdom	0013407.2	Jun 02, 2000

International Family Members for US Patent 7,265,124

Subscribe to access the full database, or Sign Up
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Argentina	032335	⤷ Sign Up
Argentina	068086	⤷ Sign Up
Austria	320430	⤷ Sign Up
Austria	555115	⤷ Sign Up
Australia	2001262874	⤷ Sign Up
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.